{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:39:16Z","timestamp":1792784356124,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Pacific Northwest Udall Center","award":["NINDS P50 NS062684"],"award-info":[{"award-number":["NINDS P50 NS062684"]}]},{"DOI":"10.13039\/100000738","name":"Department of Veterans Affairs Northwest Parkinson's Disease Research, Education, and Clinical Care Center (PADRECC)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Paul and Elizabeth Duffy Family Trust"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","prd-journal.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.parkreldis.2017.08.005","type":"journal-article","created":{"date-parts":[[2017,8,9]],"date-time":"2017-08-09T14:17:00Z","timestamp":1502288220000},"page":"1-5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["Homocysteine and cognitive function in Parkinson's disease"],"prefix":"10.1016","volume":"44","author":[{"given":"Nicole","family":"Licking","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Murchison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenna","family":"Cholerton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrus P.","family":"Zabetian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Ching","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Montine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amie L.","family":"Peterson-Hiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn A.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0896-0749","authenticated-orcid":false,"given":"James B.","family":"Leverenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph F.","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.parkreldis.2017.08.005_bib1","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1212\/01.wnl.0000306632.43729.24","article-title":"Dementia and survival in Parkinson disease: a 12-year population study","volume":"70","author":"Buter","year":"2008","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.parkreldis.2017.08.005_bib2","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1212\/01.WNL.0000032494.05619.93","article-title":"Homocysteine and cognitive function in the elderly: the Rotterdam scan study","volume":"59","author":"Prins","year":"2002","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.parkreldis.2017.08.005_bib3","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/gps.2758","article-title":"Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial","volume":"27","author":"de Jager","year":"2012","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"9","key":"10.1016\/j.parkreldis.2017.08.005_bib4","doi-asserted-by":"crossref","first-page":"e12244","DOI":"10.1371\/journal.pone.0012244","article-title":"Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial","volume":"5","author":"Smith","year":"2010","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.parkreldis.2017.08.005_bib5","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1212\/01.WNL.0000055899.24594.8E","article-title":"Effect of L-dopa on plasma homocysteine in PD patients: relationship to B-vitamin status","volume":"60","author":"Miller","year":"2003","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.parkreldis.2017.08.005_bib6","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1001\/archneur.61.6.865","article-title":"Elevated plasma homocysteine level in patients with Parkinson disease: motor, affective, and cognitive associations","volume":"61","author":"O'Suilleabhain","year":"2004","journal-title":"Archives neurology"},{"issue":"8","key":"10.1016\/j.parkreldis.2017.08.005_bib7","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1179\/016164106X110445","article-title":"Plasma homocysteine levels in patients treated with levodopa: motor and cognitive associations","volume":"28","author":"Ozer","year":"2006","journal-title":"Neurol. Res."},{"issue":"7","key":"10.1016\/j.parkreldis.2017.08.005_bib8","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/mds.22511","article-title":"Hyperhomocysteinemia in levodopa-treated patients with Parkinson's disease dementia","volume":"24","author":"Zoccolella","year":"2009","journal-title":"Mov. Disord. official J. Mov. Disord. Soc."},{"issue":"28","key":"10.1016\/j.parkreldis.2017.08.005_bib9","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.2174\/092986710792232012","article-title":"Hyperhomocysteinemia in L-dopa treated patients with Parkinson's disease: potential implications in cognitive dysfunction and dementia?","volume":"17","author":"Zoccolella","year":"2010","journal-title":"Curr. Med. Chem."},{"issue":"10","key":"10.1016\/j.parkreldis.2017.08.005_bib10","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/FPC.0b013e32835693f7","article-title":"Association of COMT, MTHFR, and SLC19A1(RFC-1) polymorphisms with homocysteine blood levels and cognitive impairment in Parkinson's disease","volume":"22","author":"Bialecka","year":"2012","journal-title":"Pharmacogenet Genomics"},{"issue":"2","key":"10.1016\/j.parkreldis.2017.08.005_bib11","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/mds.22227","article-title":"Homocysteine is not associated with global motor or cognitive measures in nondemented older Parkinson's disease patients","volume":"24","author":"Camicioli","year":"2009","journal-title":"Mov. Disord. official J. Mov. Disord. Soc."},{"issue":"10","key":"10.1016\/j.parkreldis.2017.08.005_bib12","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/mds.22522","article-title":"Homocysteine and cognitive impairment in Parkinson's disease: a biochemical, neuroimaging, and genetic study","volume":"24","author":"Rodriguez-Oroz","year":"2009","journal-title":"Mov. Disord. official J. Mov. Disord. Soc."},{"issue":"3","key":"10.1016\/j.parkreldis.2017.08.005_bib13","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.archger.2013.04.015","article-title":"Clinical significance of homocysteine (hcy) on dementia in Parkinson's disease (PD)","volume":"57","author":"Song","year":"2013","journal-title":"Arch. Gerontol. Geriatr."},{"issue":"2","key":"10.1016\/j.parkreldis.2017.08.005_bib14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3233\/JPD-130189","article-title":"Pacific Northwest Udall Center of excellence clinical consortium: study design and baseline cohort characteristics","volume":"3","author":"Cholerton","year":"2013","journal-title":"J.\u00a0Parkinson's Dis."},{"issue":"1","key":"10.1016\/j.parkreldis.2017.08.005_bib15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2990.1989.tb01147.x","article-title":"The significance of the Lewy body in the diagnosis of idiopathic Parkinson's disease","volume":"15","author":"Gibb","year":"1989","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"14","key":"10.1016\/j.parkreldis.2017.08.005_bib16","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1002\/mds.25655","article-title":"Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease","volume":"28","author":"Goldman","year":"2013","journal-title":"Mov. Disord. official J. Mov. Disord. Soc."},{"issue":"3","key":"10.1016\/j.parkreldis.2017.08.005_bib17","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/mds.26084","article-title":"Diagnosing PD-MCI by MDS Task Force criteria: how many and which neuropsychological tests?","volume":"30","author":"Goldman","year":"2015","journal-title":"Mov. Disord. official J. Mov. Disord. Soc."},{"issue":"11","key":"10.1016\/j.parkreldis.2017.08.005_bib18","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1001\/jamaneurol.2014.1455","article-title":"APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease","volume":"71","author":"Mata","year":"2014","journal-title":"JAMA neurol."},{"issue":"10","key":"10.1016\/j.parkreldis.2017.08.005_bib19","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1001\/jamaneurol.2016.2245","article-title":"Association of GBA mutations and the E326K polymorphism with motor and cognitive progression in Parkinson disease","volume":"73","author":"Davis","year":"2016","journal-title":"JAMA neurol."},{"issue":"1","key":"10.1016\/j.parkreldis.2017.08.005_bib20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/mds.26359","article-title":"GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease","volume":"31","author":"Mata","year":"2016","journal-title":"Mov. Disord. official J. Mov. Disord. Soc."},{"issue":"7","key":"10.1016\/j.parkreldis.2017.08.005_bib21","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.parkreldis.2015.04.002","article-title":"Association of cognitive domains with postural instability\/gait disturbance in Parkinson's disease","volume":"21","author":"Kelly","year":"2015","journal-title":"Park. Relat. Disord."},{"issue":"6","key":"10.1016\/j.parkreldis.2017.08.005_bib22","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/mds.25875","article-title":"Evaluation of mild cognitive impairment subtypes in Parkinson's disease","volume":"29","author":"Cholerton","year":"2014","journal-title":"Mov. Disord. official J. Mov. Disord. Soc."},{"issue":"13","key":"10.1016\/j.parkreldis.2017.08.005_bib23","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1016\/j.febslet.2006.04.088","article-title":"Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia","volume":"580","author":"Obeid","year":"2006","journal-title":"FEBS Lett."},{"issue":"2S Suppl","key":"10.1016\/j.parkreldis.2017.08.005_bib24","doi-asserted-by":"crossref","first-page":"369S","DOI":"10.1093\/jn\/130.2.369S","article-title":"Homocysteine and endothelial dysfunction: a link with cardiovascular disease","volume":"130","author":"McDowell","year":"2000","journal-title":"J.\u00a0Nutr."},{"issue":"Pt 9","key":"10.1016\/j.parkreldis.2017.08.005_bib25","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1093\/brain\/awt206","article-title":"Plasma homocysteine, Alzheimer and cerebrovascular pathology: a population-based autopsy study","volume":"136","author":"Hooshmand","year":"2013","journal-title":"Brain a J. neurology"},{"issue":"3","key":"10.1016\/j.parkreldis.2017.08.005_bib26","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/mds.25798","article-title":"Association of homocysteine with ventricular dilatation and brain atrophy in Parkinson's disease","volume":"29","author":"Sapkota","year":"2014","journal-title":"Mov. Disord. official J. Mov. Disord. Soc."},{"issue":"2","key":"10.1016\/j.parkreldis.2017.08.005_bib27","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.parkreldis.2005.10.002","article-title":"Clinical course in Parkinson's disease with elevated homocysteine","volume":"12","author":"O'Suilleabhain","year":"2006","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2017.08.005_bib28","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12883-016-0548-9","volume":"16","author":"Santos-Garcia","year":"2016","journal-title":"BMC Neurol."}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802017302869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802017302869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T13:00:36Z","timestamp":1602680436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802017302869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":28,"alternative-id":["S1353802017302869"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2017.08.005","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Homocysteine and cognitive function in Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2017.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}